Frailty in Clinical Practice

Nestle Nutrition Institute Workshop Series

Volumn 83, Issue , 2015, Pages 93-98

  Cesari, Matteo ^a   Vellas, Bruno ^a  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; COST BENEFIT ANALYSIS; ECONOMICS; ELDERLY CARE; FRAIL ELDERLY; FRANCE; GERIATRIC ASSESSMENT; HEALTH CARE COST; HUMAN; RISK; SARCOPENIA; TRENDS; VERY ELDERLY; WALKING DIFFICULTY;

AGED, 80 AND OVER; AGING; COST-BENEFIT ANALYSIS; FRAIL ELDERLY; FRANCE; GERIATRIC ASSESSMENT; HEALTH CARE COSTS; HEALTH SERVICES FOR THE AGED; HUMANS; MOBILITY LIMITATION; RISK; SARCOPENIA;

EID: 84947218489     PISSN: 16642147     EISSN: 16642155     Source Type: Book Series    
DOI: 10.1159/000382091     Document Type: Article

References (21)

1. Rodríguez-Manãs L, Feárt C, et al: Searching for an operational definition of frailty: a Delphi method based consensus statement. The frailty operative definition-consensus conference project. J Gerontol A Biol Sci Med Sci 2012; 68: 62-67.
2. Clegg A, Young J, Iliffe S, et al: Frailty in elderly people. Lancet 2013; 381: 752-762.
3. Katz S, Branch LG, Branson MH, et al: Active life expectancy. N Engl J Med 1983; 309: 1218-1224.
4. Morley JE, Vellas B, Abellan et al: Frailty consensus: a call to action. J Am Med Dir Assoc 2013; 14: 392-397.
5. Vellas B, Cestac P, Morley JE: Implementing frailty into clinical practice: we cannot wait. J Nutr Health Aging 2012; 16: 599-600.
6. Cesari M, Gambassi G, Abellan van Kan G, Vellas B: The frailty phenotype and the frailty index: different instruments for different purposes. Age Ageing 2014; 43: 10-12.
7. Subra J, Gillette-Guyonnet S, Cesari M, et al: The integration of frailty into clinical practice: preliminary results from the Gérontopôle. J Nutr Health Aging 2012; 16: 714-720.
8. Fried TR, Bradley EH, Williams CS, Tinetti ME: Functional disability and health care expenditures for older persons. Arch Intern Med 2001; 161: 2602-2607.
9. Xue QL, Varadhan R: What is missing in the validation of frailty instruments? J Am Med Dir Assoc 2014; 15: 141-142.
10. Cesari M, Vellas B: Response to the letter to the editor: 'what is missing in the validation of frailty instruments?' J Am Med Dir Assoc 2014; 15: 143-144.
11. Santos-Eggimann B, Cuénoud P, Spagnoli J, Junod J: Prevalence of frailty in middle-aged and older community-dwelling Europeans living in 10 countries. J Gerontol A Biol Sci Med Sci 2009; 64: 675-681.
12. Cesari M, Vellas B, Gambassi G: The stress of aging. Exp Gerontol 2013; 48: 451-456.
13. Bernabei R, Landi F, Gambassi G, et al: Randomised trial of impact of model of integrated care and case management for older people living in the community. BMJ 1998; 316: 1348-1351.
14. Landi F, Onder G, Russo A, et al: A new model of integrated home care for the elderly: impact on hospital use. J Clin Epidemiol 2001; 54: 968-970.
15. Stuck AE, Minder CE, Peter-Wuëst I, et al: A randomized trial of in-home visits for disability prevention in community-dwelling older people at low and high risk for nursing home admission. Arch Intern Med 2000; 160: 977-986.
16. Landi F, Onder G, Tua E, et al: Impact of a new assessment system, the MDS-HC, on function and hospitalization of homebound older people: a controlled clinical trial. J Am Geriatr Soc 2001; 49: 1288-1293.
17. Glasziou P, Moynihan R, Richards T, Godlee F: Too much medicine; too little care. BMJ 2013; 347:f4247.
18. Moreno-Aguilar M, Garcia-Lara JMA, Aguilar-Navarro S, et al: The phenotype of frailty and health-related quality of life. J Frailty Aging 2013; 2: 2-7.
19. O'Connell MDL, Tajar A, O'Neill TW, et al: Frailty is associated with impaired quality of life and falls in middle-aged and older European men. J Frailty Aging 2013; 2: 77-83.
20. Marshall SE, Cheng B, Northridge ME, et al: Integrating oral and general health screening at senior centers for minority elders. Am J Public Health 2013; 103: 1022-1025.
21. Barron S, Balanda K, Hughes J, Fahy L: National and subnational hypertension prevalence estimates for the Republic of Ireland: better outcome and risk factor data are needed to produce better prevalence estimates. BMC Public Health 2014; 14: 24.